Failure of postnatal closure of the ductus arteriosus (DA) remains a common complication of very preterm birth. About a third of infants born before 30 weeks gestation will develop clinical signs ...

Current Controversies in the Diagnosis and Treatment of Patent Ductus Arteriosus in Preterm Infants Nick Evans, DM, MRCPCH Disclosures Adv Neonatal Care. 2003;3 (4) 0 ...

Specialized cardiovascular surgery centers in the city provide high-tech care for children suffering from any variety ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants.

SHOULD closure of a patent ductus arteriosus with reversal of flow be attempted? If so, how can the high surgical mortality hitherto reported 1–3 be reduced? An attempt is made to answer these ...

Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease.

Coarctation of the aorta (CoA ) is a well-known congenital heart disease (CHD) , which is often associated with several other cardiac and vascular anomalies, such as bicuspid aortic valve (BAV), ...

Ductal-dependent congenital heart disease involves an irregularity with the ductus arteriosus, an opening between the aorta and the pulmonary artery. This issue means that blood can’t flow as ...

The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with ibuprofen would improve short-ter ...